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This issue of Personality and Mental Health is 
devoted in its entirety to comments on the 
National Institute of Clinical Excellence’s 
Guidelines for the Treatment of Antisocial 
Personality Disorder and Borderline Personality 
Disorder. Both are products of the UK’s National 
Institute for Health and Clinical Excellence 
(NICE), and were issued in January 2009. These 
guidelines can be found at http://guidance.nice.org.
uk/CG77 for antisocial personality disorder, and at 
http://guidance.nice.org.uk/CG78 for borderline 
personality disorder. Each guideline has a com-
plete version, a shortened version (that can be 
thought of as a detailed  executive summary) and 
a handy ‘quick reference guide’.
What is key in the approach in these guidelines 
is the emphasis on both treatment and manage-
ment. Anyone who has worked with these two 
groups of patients appreciates fully that manage-
ment of the patient and of the treatment of the 
patient may be as important as the actual treat-
ment choices themselves. These are cohorts of 
patients that have legendary, even if not always 
accurate, reputations for being very diffi cult if not 
impossible to treat. While the view of the resis-
tance of these patient groups to treatment may 
have been modifi ed somewhat by the recent 
follow-along studies of borderline personality dis-
order (Skodol et al., 2005; Zanarini, Frankenburg, 
Hennen, Reich, & Silk, 2005), as well as the 
 development of a number of successful evidence-
based treatments for borderline personality disor-
der (Bateman & Fonagy, 1999; Clarkin, Levy, 
Lenzenweger, & Kernberg, 2007; Davidson et al., 
2006; Giesen-Bloo et al., 2006; Linehan et al., 
2006), the problems in developing and implement-
ing successful treatment for those with antisocial 
personality disorder remain mostly elusive despite 
the thorough and helpful work of the NICE 
guideline.
The guidelines are unique and valuable in that 
not only do they provide us a set of ‘dos’ and ‘do 
nots’ in the treatment of these disorders, but they 
also address issues such as clinician expertise, 
training of providers, coordination of care and 
organization of healthcare services that can opti-
mize the provision of care for these patients. This 
is particularly relevant in the current debate about 
healthcare in the United States where I practice 
and where the fragmentation of cost coverage for 
healthcare can only add to a lack of coordination 
of services for people who above all need structure 
and a consistent and informed multi-disciplinary 
approach to their care. A national health pro-
gramme, such as exists in the UK, can allow and 
foster the development and implementation of 
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coordinated services that we can only wish for in 
the United States.
There has often been a discussion as to whether 
borderline personality disorder and antisocial per-
sonality disorder are merely two sides of the same 
coin. For example, while borderline patients appear 
extremely sensitive to interpersonal interactions 
(even though they may not be very good at inter-
preting or planning for them and ultimately end 
up straining these relationships), antisocial per-
sonality patients are typically viewed as immune 
to these interactions while many of them may at 
the same time be astute in their ability to charm 
others. For antisocial personality patients, this may 
be a stereotype and simplistic, but we need further 
research here. Borderline patients appear at times 
to act out against and harm themselves when dis-
tressed or overwhelmed, while antisocial patients 
appear to act out against society (even though 
they might rarely acknowledge the awareness 
of their own distress). These guidelines, however, 
at least in their conclusions about management 
and treatment, would suggest that these two groups 
are at times quite different populations, and 
approaches that work for one may not work for the 
other.
What appears to be similar in the recommen-
dations for each of the patient groups is that treat-
ment be planned, structured, coordinated and 
manualized to be able to provide true guidance 
when sailing the complex, chaotic and counter-
transferential-laden waters of trying to provide 
good care for these individuals.
One additional point deserves mentioning. The 
NICE guidance suggests that with both of these 
patient populations, treatment will not only be 
complex, but will have to take place over a sub-
stantial period of time. Treatment that lasts only 
a couple of months does not appear to suffi ce with 
these complicated patients. But a sustained, orga-
nized, informed and collaborative endeavor can 
provide successes where in the past we could only 
believe that the idea of success was an illusion 
(Bateman & Zanarini, 2008).
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